Prognostic role of circulating tumor cells and disseminated tumor cells in patients with prostate cancer: a systematic review and meta-analysis

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Tumor Biology

• Publication date

  2014-02-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s13277-014-1731-5PMID 24563278
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Circulating Tumor Cells and Prognosis of Patients with Resectable Colorectal Liver Metastases or Widespread Metastatic Colorectal Cancer: A Meta-Analysis

  2013cited by this paper
• Detection of circulating tumor cells in different stages of prostate cancer

  2013cited by this paper
• Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition

  2013cited by this paper
• Tumor cell dissemination: emerging biological insights from animal models and cancer patients.

  2013cited by this paper
• Prognostic significance of circulating tumor cell count in patients with metastatic hormone-sensitive prostate cancer.

  2012cited by this paper
• Meta-analysis of circulating tumor cells as a prognostic marker in lung cancer.

  2012cited by this paper
• Meta-Analysis of the Prognostic Value of Circulating Tumor Cells in Breast Cancer

  2012cited by this paper
• Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer.

  2012cited by this paper
• EAU guidelines on prostate cancer . Part I : screening , diagnosis , and treatment of clinically localised disease

  2012cited by this paper
• Circulating tumor cells in prostate cancer: a potential surrogate marker of survival.

  2012cited by this paper
• EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease.

  2011cited by this paper
• Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer.

  2011cited by this paper
• Global cancer statistics

  2011cited by this paper
• Circulating endothelial cells, circulating tumour cells, tissue factor, endothelin-1 and overall survival in prostate cancer patients treated with docetaxel.

  2010cited by this paper
• Association of circulating tumor cells with tumor‐related methylated DNA in patients with hormone‐refractory prostate cancer

  2010cited by this paper
• Prostate stem cell antigen mRNA in peripheral blood as a potential predictor of biochemical recurrence in high‐risk prostate cancer

  2010cited by this paper
• Prognostic significance of circulating tumor cells in patients with hormone refractory prostate cancer.

  2009cited by this paper
• Prognostic relevance of circulating tumor cells (CTCs) in peripheral blood of breast cancer patients before and after adjuvant chemotherapy – translational research program of the German SUCCESS-trial.

  2009cited by this paper
• Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience.

  2009cited by this paper
• Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data.

  2009cited by this paper
• Disseminated Tumor Cells in Prostate Cancer Patients after Radical Prostatectomy and without Evidence of Disease Predicts Biochemical Recurrence

  2009cited by this paper
• Perioperative activation of disseminated tumor cells in bone marrow of patients with prostate cancer.

  2009cited by this paper
• Urokinase‐plasminogen‐activator receptor expression in disseminated tumour cells in the bone marrow and peripheral blood of patients with clinically localized prostate cancer

  2009cited by this paper
• Circulating Tumor Cells in Patients with Castration-Resistant Prostate Cancer Baseline Values and Correlation with Prognostic Factors

  2009cited by this paper
• Prognostic relevance of circulating tumor cells (CTCs) in peripheral blood of breast cancer patients before and after adjuvant chemotherapy: The German SUCCESS-Trial

  2008cited by this paper
• Circulating Tumor Cell Detection Predicts Early Metastatic Relapse After Neoadjuvant Chemotherapy in Large Operable and Locally Advanced Breast Cancer in a Phase II Randomized Trial

  2008cited by this paper
• Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer.

  2008cited by this paper
• Detection, clinical relevance and specific biological properties of disseminating tumour cells

  2008cited by this paper
• Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer.

  2008cited by this paper
• Combined androgen blockade therapy can convert RT-PCR detection of prostate-specific antigen (PSA) and prostate-specific membrane antigen (PSMA) transcripts from positive to negative in the peripheral blood of patients with clinically localized prostate cancer and increase biochemical failure-free s

  2007cited by this paper
• Circulating Tumor Cell Analysis in Patients with Progressive Castration-Resistant Prostate Cancer

  2007cited by this paper
• Practical methods for incorporating summary time-to-event data into meta-analysis

  2007cited by this paper
• Impact of disseminated tumor cells in bone marrow at diagnosis in patients with nonmetastatic prostate cancer treated by definitive radiotherapy

  2007cited by this paper
• Random-effects model for meta-analysis of clinical trials: an update.

  2007cited by this paper
• Isolation of rare circulating tumour cells in cancer patients by microchip technology

  2007cited by this paper
• Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review.

  2006cited by this paper
• Re: Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. K. Eichler, S. Hempel, J. Wilby, L. Myers, L. M. Bachmann and J. Kleijnen, J Urol, 175: 1605-1612, 2006.

  2006cited by this paper
• Circulating tumor cells predict survival in patients with metastatic prostate cancer.

  2005cited by this paper
• A pooled analysis of bone marrow micrometastasis in breast cancer.

  2005cited by this paper
• Assessing the clinical impact of prognostic factors: When is "statistically significant" clinically useful?

  2004cited by this paper
• RT-PCR for PSA as a prognostic factor for patients with clinically localized prostate cancer treated with radiotherapy.

  2003cited by this paper
• Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer.

  2003cited by this paper
• Reverse transcription-polymerase chain reaction detection of prostate-specific antigen, prostate-specific membrane antigen, and prostate stem cell antigen in one milliliter of peripheral blood: value for the staging of prostate cancer.

  2002cited by this paper
• A history of prostate cancer treatment

  2002cited by this paper
• Presence of circulating prostate cancer cells in African American males adversely affects survival.

  2002cited by this paper
• Preoperative blood reverse transcriptase-PCR assays for prostate-specific antigen and human glandular kallikrein for prediction of prostate cancer progression after radical prostatectomy.

  2002cited by this paper
• EAU guidelines on prostate cancer.

  2001cited by this paper
• Detection of circulating prostate derived cells in patients with prostate adenocarcinoma is an independent risk factor for tumor recurrence.

  2000cited by this paper
• Clinical and molecular followup after radical retropubic prostatectomy.

  1999cited by this paper
• Presence of circulating prostate cells in the bone marrow of patients undergoing radical prostatectomy is predictive of disease-free survival.

  1997cited by this paper
• Prognostic significance of detection of prostate-specific antigen transcripts in the peripheral blood of patients with metastatic androgen-independent prostatic carcinoma.

  1997cited by this paper
• Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases.

  1996cited by this paper
• Original Articles PREOPERATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION FOR PROSTATE SPECIFIC ANTIGEN PREDICTS TREATMENT FAILURE FOLLOWING RADICAL PROSTATECTOMY

  1996cited by this paper
• Preoperative reverse transcriptase polymerase chain reaction for prostate specific antigen predicts treatment failure following radical prostatectomy.

  1996cited by this paper
• Publication bias in clinical research.

  1991cited by this paper
• Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen.

  1990cited by this paper

• A narrative review of the current state of circulating tumor cells in prostate cancer diagnostic

  2025cites this paper
• Navigating circulating tumour cells and tumour microemboli: Where we stand in bridging their molecular dynamics with clinical translation.

  2025cites this paper
• Intraoperative Cell Salvage in Oncologic Surgery: A Comprehensive Review

  2025cites this paper
• Prognostic Significance of Disseminated Tumor Cells in Bone Marrow for Endometrial Carcinoma Patients

  2024cites this paper
• Single-Cell Analysis of Bone-Marrow-Disseminated Tumour Cells

  2024cites this paper
• Blood-based circulating biomarkers for prediction of immune-checkpoint inhibitors efficacy in renal cell carcinoma

  2024cites this paper
• The 5-WS of targeting DNA-damage repair (DDR) pathways in prostate cancer.

  2024cites this paper
• An indocyanine green-based liquid biopsy test for circulating tumor cells for pediatric liver cancer

  2024cites this paper
• Diagnostic and prognostic value of circulating tumor cells in renal cell cancer: A systematic review and meta-analysis.

  2024cites this paper
• An indocyanine green-based liquid biopsy test for circulating tumor cells for pediatric liver cancer

  2023cites this paper
• Bioplatforms in liquid biopsy: advances in the techniques for isolation, characterization and clinical applications

  2022cites this paper
• Malignancy Assessment Using Gene Identification in Captured Cells Algorithm for the Prediction of Malignancy in Women With a Pelvic Mass

  2022cites this paper
• Application of Primary/Secondary Circulating Tumor Cells for the Prediction of Biochemical Recurrence in Nonmetastatic Prostate Cancer Patients following Radical Prostatectomy or Radiotherapy: A Meta-Analysis

  2021cites this paper
• Circulating Biomarkers in Head and Neck Cancer

  2021cites this paper
• Prognostic Value of Cell-Surface Vimentin-Positive CTCs in Pediatric Sarcomas

  2021cites this paper
• Diagnostic and Prognostic Value of Cell-Surface Vimentin-Positive Circulating Tumor Cells in Pediatric Sarcoma Patients

  2021cites this paper
• Comparison of hormonal receptor expression and HER2 status between circulating tumor cells and breast cancer metastases

  2021cites this paper
• Biomarker in Active Surveillance for Prostate Cancer: A Systematic Review

  2021cites this paper
• Cell surface vimentin‐positive circulating tumor cell‐based relapse prediction in a long‐term longitudinal study of postremission neuroblastoma patients

  2020cites this paper
• New Screening Test Improves Detection of Prostate Cancer Using Circulating Tumor Cells and Prostate-Specific Markers

  2020cites this paper
• Microfluidics Technology for Label-Free Isolation of Circulating Tumor Cells

  2020cites this paper
• UROLOGICAL ONCOLOGY Minimal Residual Disease Defines the Risk and Time to Biochemical Failure in Patients with Pt2 and Pt3a Prostate Cancer Treated With Radical Prostatectomy: An Observational Prospective Study

  2020cites this paper
• Isolation and Enumeration of CTC in Colorectal Cancer Patients: Introduction of a Novel Cell Imaging Approach and Comparison to Cellular and Molecular Detection Techniques

  2020cites this paper
• Prognostic Value of Circulating Tumour Cells detected with the CellSearch System in Esophageal Cancer Patients: A Systematic Review and Meta-Analysis

  2020cites this paper
• Prognostic value of circulating tumor cells detected with the CellSearch system in esophageal cancer patients: a systematic review and meta-analysis

  2020cites this paper
• Circulating tumor cells as Trojan Horse for understanding, preventing, and treating cancer: a critical appraisal

  2020cites this paper
• Subtypes of minimal residual disease, association with Gleason score, risk and time to biochemical failure in pT2 prostate cancer treated with radical prostatectomy

  2019cites this paper
• Circulating tumor markers: harmonizing the yin and yang of CTCs and ctDNA for precision medicine

  2019influential citation
• Circulating Tumor Cells: Overview and Opportunities in Cytology.

  2019cites this paper
• Prognostic and Predictive Role of Circulating Tumor Cells

  2019cites this paper
• CTCs analysis: an update on technological progress.

  2019cites this paper
• Células prostáticas circulantes y micro-metástasis en médula ósea determinantes en el riesgo y en el tiempo de progresión bioquímica en cáncer prostático localizado

  2019cites this paper
• Reduced pim-1 expression increases chemotherapeutic drug sensitivity in human androgen-independent prostate cancer cells by inducing apoptosis.

  2019cites this paper
• Molecular Biomarkers in Localized Prostate Cancer: ASCO Guideline.

  2019cites this paper
• MAGE‐A gene expression in peripheral blood serves as a poor prognostic marker for patients with lung cancer

  2018cites this paper
• EpCAM-based assays for epithelial tumor cell detection in cerebrospinal fluid

  2018cites this paper
• Circulating Tumor DNA and Circulating Tumor Cells for Cancer Management ( Liquid Biopsy )

  2018cites this paper
• Circulating Tumor DNA and Circulating Tumor Cells for Cancer Management (Liquid Biopsy)

  2018cites this paper
• Progress in Circulating Tumor Cell Research Using Microfluidic Devices

  2018cites this paper
• Exosome: A rising star in the era of precision oncology

  2018cites this paper
• THE OFFICIAL PUBLICATION OF THE INTERNATIONAL ASSOCIATION FOR DENTAL RESEARCH

  2018cites this paper
• Circulating tumor cells as a potential biomarker in diagnosis of lung cancer: a systematic review and meta‐analysis

  2018cites this paper
• Minimal residual disease in prostate cancer patients after primary treatment: theoretical considerations, evidence and possible use in clinical management

  2018cites this paper
• Minimum Residual Disease in Patients Post Radical Prostatectomy for Prostate Cancer: Theoretical Considerations, Clinical Implications and Treatment Outcome

  2018cites this paper
• Prognostic value of circulating tumor cells detected with the CellSearch System in patients with gastric cancer: evidence from a meta-analysis

  2018cites this paper
• Circulating and disseminated tumor cells in pancreatic cancer and their role in patient prognosis: a systematic review and meta-analysis

  2017cites this paper
• MP-2.235 Assays of Genetic Expression in Tumor Tissue as a Technique to Determine Prognosis in Patients with Breast Cancer MP-2.280 Genetic and Protein Biomarkers for the Diagnosis and Assessment of Prostate Cancer

  2017cites this paper
• Are Liquid Biopsies Applied Across Every Type of Solid Tumours

  2017cites this paper
• "Stealth dissemination" of macrophage-tumor cell fusions cultured from blood of patients with pancreatic ductal adenocarcinoma

  2017cites this paper
• Circulating Tumor DNA and Circulating Tumor Cells for Cancer Management ( Liquid Biopsy ) Policy # 00497

  2017cites this paper
• The evolution of chemotherapy for the treatment of prostate cancer

  2017cites this paper
• Meta-analyses of the clinicopathological and prognostic significance of circulating tumor cells in esophageal cancer

  2017cites this paper
• Circulating Tumor DNA and Circulating Tumor Cells for Cancer Management ( Liquid Biopsy ) Policy # 00497

  2017cites this paper
• Detection of Circulating Tumor Cells in the Management of Patients with Cancer Effective : August 1 , 2017

  2017cites this paper
• Liquid Biopsy for Cancer: Circulating Tumor Cells, Circulating Free DNA or Exosomes?

  2017cites this paper
• Circulating Tumor DNA and Circulating Tumor Cells for Cancer Management (Liquid Biopsy)

  2017cites this paper
• Circulating Tumor Cells in Genitourinary Malignancies: An Evolving Path to Precision Medicine

  2017cites this paper
• Les biomarqueurs circulants du cancer : avantages et perspectives

  2016cites this paper
• The diagnostic and prognostic value of CTC enumeration by CellSearch System in prostate cancer : a systematic review and meta-analysis

  2016cites this paper
• Central, But Not Peripheral, Circulating Tumor Cells are Prognostic in Patients Undergoing Resection of Colorectal Cancer Liver Metastases

  2016cites this paper
• Gynecological surveillance in high risk women.

  2016cites this paper
• Gynaecological surveillance in high risk women

  2016cites this paper
• High-Resolution Genomic Profiling of Disseminated Tumor Cells in Prostate Cancer.

  2016cites this paper
• TRAIL-coated leukocytes that prevent the bloodborne metastasis of prostate cancer.

  2016cites this paper
• Circulating Tumor DNA and Circulating Tumor Cells for Cancer Diagnosis and Management ( Liquid Biopsy )

  2016cites this paper
• Prognostic Value of Circulating Tumor Cells in Castration Resistant Prostate Cancer: A Meta-analysis.

  2016cites this paper
• Clinical Application of Circulating Tumour Cells in Prostate Cancer: From Bench to Bedside and Back

  2016cites this paper
• Circulating Tumor DNA and Circulating Tumor Cells for Cancer Diagnosis and Management ( Liquid Biopsy )

  2016cites this paper
• Circulating tumor markers: harmonizing the yin and yang of CTCs and ctDNA for precision medicine.

  2016cites this paper
• Circulating Tumour Cells as an Independent Prognostic Factor in Patients with Advanced Oesophageal Squamous Cell Carcinoma Undergoing Chemoradiotherapy

  2016cites this paper
• Chapter 19 – Breast and Prostate Cancers: A Comparison of Two Endocrinologic Malignancies

  2016cites this paper
• Circulating Tumor Cells in Diagnosing Lung Cancer: Clinical and Morphologic Analysis.

  2015cites this paper
• Circulating Tumor Cells in Biochemical Recurrence of Prostate Cancer.

  2015cites this paper
• Cancer Nanotechnology Plan 2015

  2015cites this paper
• Macrophage-Tumor Cell Fusions from Peripheral Blood of Melanoma Patients

  2015cites this paper
• Energy Deposition and Nanodosimetry of Iodine-125 and Tin-117m Labeled Gold Nanoparticles: A Computational Model Using Geant4-DNA

  2015cites this paper
• Biomarkers as Prognostic, Predictive, and Surrogate Endpoints

  2015cites this paper
• Circulating tumor cell detection in high-risk non-metastatic prostate cancer

  2014cites this paper
• Comment on Ma XL et al.: Prognostic role of circulating tumor cells and disseminated tumor cells in patients with prostate cancer: a systematic review and meta-analysis

  2014cites this paper